生理学报
生理學報
생이학보
ACTA PHYSIOLOGICA SINICA
2005年
3期
373-378
,共6页
汤勇波%王乾蕾%朱炳阳%黄红林%廖端芳
湯勇波%王乾蕾%硃炳暘%黃紅林%廖耑芳
탕용파%왕건뢰%주병양%황홍림%료단방
金雀异黄酮%一氧化氮%内皮型一氧化氮合酶%小凹蛋白
金雀異黃酮%一氧化氮%內皮型一氧化氮閤酶%小凹蛋白
금작이황동%일양화담%내피형일양화담합매%소요단백
genistein%nitric oxide%endothelial nitric oxide synthase%caveolins
观察金雀异黄酮(genistein)替代治疗对卵巢切除大鼠心肌中一氧化氮(nitric oxide,NO)和内皮型一氧化氮合酶(endothelial nitric oxide synthase,eNOS)的影响.成年雌性Sprague-Dawley大鼠经双侧卵巢切除术,假手术组作为对照,术后三周将行卵巢切除术的大鼠随机分为低剂量genistein(0.5 mg/kg·d1)、高剂量genistein(5.0 mg/kg·d-1)、17-β雌二醇(0.1 mg/kg·d-1)和模型组(100μl/d芝麻油),各组均皮下注射给药并给予不含大豆的饲料喂养6周,测定大鼠尾动脉血压、心率,麻醉后放血处死大鼠称量子宫重量;放免法检测血浆中总雌二醇,亚硝酸还原酶法检测心肌匀浆中NO,Western blot检测心肌中eNOS的表达以及eNOS的调节蛋白小凹蛋白-1(caveolin-1)和钙调素(calmodulin)的表达情况.结果显示各组间大鼠血压无显著性差异,同17-β雌二醇一样,genistein能呈剂量依赖性地增加心肌组织中eNOS表达量和NO生成,同时genistein能明显降低内源性eNOS活性抑制物caveolin-1的表达,而不影响eNOS活性正性调节蛋白钙调素的表达.与溶媒对照组比较,0.5 mg/kg·d-1的genistein不增加子宫重量,5.0 mg/kg·d-1的genistein增加子宫重量3倍,但较17-β雌二醇(增加6倍)的作用小(P<0.01).上述结果提示,植物雌激素genistein剂量依赖性地上调心肌组织eNOS的活性并增加NO的生成,减少抑制eNOS活性的小凹蛋白-1表达.
觀察金雀異黃酮(genistein)替代治療對卵巢切除大鼠心肌中一氧化氮(nitric oxide,NO)和內皮型一氧化氮閤酶(endothelial nitric oxide synthase,eNOS)的影響.成年雌性Sprague-Dawley大鼠經雙側卵巢切除術,假手術組作為對照,術後三週將行卵巢切除術的大鼠隨機分為低劑量genistein(0.5 mg/kg·d1)、高劑量genistein(5.0 mg/kg·d-1)、17-β雌二醇(0.1 mg/kg·d-1)和模型組(100μl/d芝痳油),各組均皮下註射給藥併給予不含大豆的飼料餵養6週,測定大鼠尾動脈血壓、心率,痳醉後放血處死大鼠稱量子宮重量;放免法檢測血漿中總雌二醇,亞硝痠還原酶法檢測心肌勻漿中NO,Western blot檢測心肌中eNOS的錶達以及eNOS的調節蛋白小凹蛋白-1(caveolin-1)和鈣調素(calmodulin)的錶達情況.結果顯示各組間大鼠血壓無顯著性差異,同17-β雌二醇一樣,genistein能呈劑量依賴性地增加心肌組織中eNOS錶達量和NO生成,同時genistein能明顯降低內源性eNOS活性抑製物caveolin-1的錶達,而不影響eNOS活性正性調節蛋白鈣調素的錶達.與溶媒對照組比較,0.5 mg/kg·d-1的genistein不增加子宮重量,5.0 mg/kg·d-1的genistein增加子宮重量3倍,但較17-β雌二醇(增加6倍)的作用小(P<0.01).上述結果提示,植物雌激素genistein劑量依賴性地上調心肌組織eNOS的活性併增加NO的生成,減少抑製eNOS活性的小凹蛋白-1錶達.
관찰금작이황동(genistein)체대치료대란소절제대서심기중일양화담(nitric oxide,NO)화내피형일양화담합매(endothelial nitric oxide synthase,eNOS)적영향.성년자성Sprague-Dawley대서경쌍측란소절제술,가수술조작위대조,술후삼주장행란소절제술적대서수궤분위저제량genistein(0.5 mg/kg·d1)、고제량genistein(5.0 mg/kg·d-1)、17-β자이순(0.1 mg/kg·d-1)화모형조(100μl/d지마유),각조균피하주사급약병급여불함대두적사료위양6주,측정대서미동맥혈압、심솔,마취후방혈처사대서칭양자궁중량;방면법검측혈장중총자이순,아초산환원매법검측심기균장중NO,Western blot검측심기중eNOS적표체이급eNOS적조절단백소요단백-1(caveolin-1)화개조소(calmodulin)적표체정황.결과현시각조간대서혈압무현저성차이,동17-β자이순일양,genistein능정제량의뢰성지증가심기조직중eNOS표체량화NO생성,동시genistein능명현강저내원성eNOS활성억제물caveolin-1적표체,이불영향eNOS활성정성조절단백개조소적표체.여용매대조조비교,0.5 mg/kg·d-1적genistein불증가자궁중량,5.0 mg/kg·d-1적genistein증가자궁중량3배,단교17-β자이순(증가6배)적작용소(P<0.01).상술결과제시,식물자격소genistein제량의뢰성지상조심기조직eNOS적활성병증가NO적생성,감소억제eNOS활성적소요단백-1표체.
This study examined whether genistein influences the production of nitric oxide (NO) and expression of endothelial nitric oxide synthase (eNOS) and the modulators of eNOS activity in ovariectomized (OVX) rat hearts. Female mature Sprague-Dawley rats were subjected to bilateral ovariectomy, OVX rats were randomly divided into four groups: 17β-estradiol (0.1 mg/kg, s.c. daily) was used as the positive control; low dose of genistein (0.5 mg/kg, s.c. daily); high dose of genistein(5.0 mg/kg, s.c. daily) and model. Sham operations as controls, the treatment lasted 6 weeks. Blood pressure, heart rate, plasma estradiol, heart and uterine weights were measured. Nitrite production in the myocardium was determined by nitrate reductase method. Protein level of eNOS, caveolin-1 and calmodulin was determined by Western blot. The results showed that nitrite production and eNOS protein in homogenized ventricular tissue was attenuated by approximately 53% and 67% in OVX rats compared with those in sham rats, respectively. Genistein increased similar to that in sham operated rats. Administration of genistein also increased eNOS protein expression in OVX rats myocardium with a concomitant decrease in the expression of caveolin-1, an endogenous eNOS inhibitory protein. Another eNOS stimulatory protein,calmodulin, was unchanged in these treatments. These effects were also observed in rats treated with 17β-estradiol. Genistein at the results suggest that genistein supplementation and estrogen replacement therapy directly increase eNOS functional activity and NO production in the hearts of the OVX rats, but genistein has less side effects on the reproductive system than 17β-estradiol.